treosulfan has been researched along with Preleukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ersbøll, J; Keiding, N; Larsen, MS; Larsen, SO; Nissen, NI; Pedersen-Bjergaard, J; Philip, P; Schultz, H; Sørensen, HM | 1 |
1 other study(ies) available for treosulfan and Preleukemia
| Article | Year |
|---|---|
Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
Topics: Acute Disease; Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Infant; Leukemia; Lymphoma; Male; Mechlorethamine; Middle Aged; Myeloproliferative Disorders; Nitrosourea Compounds; Ovarian Neoplasms; Preleukemia; Risk; Time Factors | 1985 |